|Mr. Timothy C. Crew||CEO & Director||1.51M||N/A||1961|
|Mr. John Kozlowski||VP of Fin. & CFO||567.2k||N/A||1972|
|Mr. John M. Abt||VP and Chief Quality & Operations Officer||575.42k||N/A||1965|
|Mr. Samuel H. Israel||Gen. Counsel & Chief Legal Officer||667.12k||N/A||1962|
|Mr. Martin P. Galvan||Consultant||714.48k||N/A||1952|
Lannett Company, Inc. develops, manufactures, packages, markets, and distributes generic versions of brand pharmaceutical products in the United States. The company offers solid oral and extended release, topical, liquid, nasal, and oral solution finished dosage forms of drugs that address a range of therapeutic areas, as well as ophthalmic, nasal, patch, foam, buccal, sublingual, suspensions, soft gel, injectable, and oral dosages. It also provides its products for various medical indications, such as antibiotic, anti-psychosis, cardiovascular, central nervous system, gallstone, gastrointestinal, glaucoma, migraine, muscle relaxant, pain management, respiratory, thyroid deficiency, urinary, and others medical indications. The company's primary products include Levothyroxine Sodium tablets, Fluphenazine tablets, Verapamil SR tablets, Ursodiol capsules, Methylphenidate CD capsules, Omeprazole capsules, Pantoprazole Sodium DR tablets, Sumatriptan Nasal spray, Dicyclomine tablets and capsules, Metolazone tablets, and Methylphenidate Hydrochloride ER, as well as cocaine hydrochloride solution. It sells its pharmaceutical products to generic pharmaceutical distributors, drug wholesalers, chain drug retailers, private label distributors, mail-order pharmacies, other pharmaceutical companies, managed care organizations, hospital buying groups, governmental entities, and health maintenance organizations. The company has supply and development agreements with Summit Bioscience LLC, HEC Pharm Group, Andor Pharmaceuticals LLC, Dexcel Pharma, Elite Pharmaceuticals, RivoPharm, and various other companies. Lannett Company, Inc. was founded in 1942 and is headquartered in Philadelphia, Pennsylvania.
Lannett Company, Inc.’s ISS Governance QualityScore as of October 4, 2019 is 4. The pillar scores are Audit: 5; Board: 6; Shareholder Rights: 2; Compensation: 4.